|
PMS2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.984100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.720000E-01 |
| Normal-vs-Stage2 |
6.899200E-01 |
| Normal-vs-Stage3 |
1.918410E-03 |
| Normal-vs-Stage4 |
6.563700E-02 |
| Stage1-vs-Stage2 |
8.231000E-01 |
| Stage1-vs-Stage3 |
4.855700E-03 |
| Stage1-vs-Stage4 |
1.717820E-01 |
| Stage2-vs-Stage3 |
2.856400E-02 |
| Stage2-vs-Stage4 |
2.518200E-01 |
| Stage3-vs-Stage4 |
3.570400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.301600E-02 |
| Normal-vs-AfricanAmerican |
9.529600E-01 |
| Normal-vs-Asian |
2.795800E-01 |
| Caucasian-vs-AfricanAmerican |
7.666400E-02 |
| Caucasian-vs-Asian |
1.082960E-01 |
| AfricanAmerican-vs-Asian |
4.284200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.740700E-03 |
| Normal-vs-Female |
8.509200E-01 |
| Male-vs-Female |
3.155100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.336620E-01 |
| Normal-vs-Age(41-60Yrs) |
3.304000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.880160E-02 |
| Normal-vs-Age(81-100Yrs) |
4.287200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.777400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.644600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.513200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.004100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.936200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.619600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.748000E-01 |
| Normal-vs-Grade 2 |
2.443200E-01 |
| Normal-vs-Grade 3 |
1.257400E-01 |
| Normal-vs-Grade 4 |
6.041800E-04 |
| Grade 1-vs-Grade 2 |
2.573600E-01 |
| Grade 1-vs-Grade 3 |
1.870350E-01 |
| Grade 1-vs-Grade 4 |
7.690500E-02 |
| Grade 2-vs-Grade 3 |
6.543200E-01 |
| Grade 2-vs-Grade 4 |
5.637200E-03 |
| Grade 3-vs-Grade 4 |
1.790040E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.903600E-01 |
| Normal-vs-ccB subtype |
1.915390E-03 |
| ccA subtype-vs-ccB subtype |
1.182650E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.667550E-01 |
| Normal-vs-N1 |
6.490000E-01 |
| N0-vs-N1 |
8.458200E-01 |
|
|
